2015
DOI: 10.1016/j.acra.2015.03.003
|View full text |Cite
|
Sign up to set email alerts
|

Screening Mammography

Abstract: Until we have better screening procedures that identify who really has cancer and needs to be treated, the risk of overdiagnosis relative to the benefit of screening merits more effective public and professional education. Radiologists, pathologists, and other professionals involved with screening mammography should recognize that the potential harm of overdiagnosis is downplayed or not discussed with the patient and family, despite agreement that the objective is informed choice.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
4
0

Year Published

2015
2015
2021
2021

Publication Types

Select...
6

Relationship

1
5

Authors

Journals

citations
Cited by 15 publications
(4 citation statements)
references
References 48 publications
0
4
0
Order By: Relevance
“…3,6,7 Mounting evidence documents the harms of screening: frequent false positive results that lead to a cascade of testing, biopsies, anxiety, and overdiagnosis. [8][9][10] These harms increase with more frequent screening. While mammography screening reduces breast cancer mortality, 10 the absolute benefit is greater for women at higher risk of developing breast cancer.…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…3,6,7 Mounting evidence documents the harms of screening: frequent false positive results that lead to a cascade of testing, biopsies, anxiety, and overdiagnosis. [8][9][10] These harms increase with more frequent screening. While mammography screening reduces breast cancer mortality, 10 the absolute benefit is greater for women at higher risk of developing breast cancer.…”
Section: Introductionmentioning
confidence: 99%
“…[8][9][10] These harms increase with more frequent screening. While mammography screening reduces breast cancer mortality, 10 the absolute benefit is greater for women at higher risk of developing breast cancer. In contrast to a traditional Bonesize-fits-all^approach, risk-based screening would personalize recommendations in order to minimize harms and maximize benefits of screening.…”
Section: Introductionmentioning
confidence: 99%
“…With the disparate recommendations issued by organizations in the U.S. and elsewhere [ 25 29 ] and suggestions for personalized screening [ 30 32 ], we sought to examine the relationship between mammography screening frequency and mortality risk with consideration of age and estimated personal breast cancer risk category in the CTS, a large, well-characterized cohort of women with 20 years of follow-up. Since the biggest uncertainty and inconsistency between the recommendations, in addition to starting and stopping ages, pertains to biennial versus annual mammography, our analysis was focused on these two groups.…”
Section: Discussionmentioning
confidence: 99%
“…Primary prevention of breast cancer by endocrine therapy has side effects and is not absolute, whereas prophylactic surgery is very effective [2] but socially and emotionally burdensome. Secondary prevention by early detection through mammographic screening can reduce mortality but at the cost of overdiagnosis and the burden of false-positive results [3,4]. Stratification of women according to the risk of developing breast cancer could provide a persuasive rationale for surgical intervention as well as improve the efficacy of risk-reduction and screening strategies by tailoring starting age and frequency [5, 6•].…”
Section: Introductionmentioning
confidence: 99%